ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs MXN
16.9724
0.00%
Brent Oil
82.765
0.00%
Bitcoin
63,555.51
1.06%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Paratek Pharmaceuticals Inc (PRTK)

  7. Paratek Pharmaceuticals Inc (PRTK) Noticias

PRTK Paratek Pharmaceuticals Inc

2.23
0.00 (0.00%)
02 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Paratek Pharmaceuticals Inc PRTK NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 2.23 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
2.23 2.23
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
05/10/202307:00GLOBEParatek Pharmaceuticals to Present NUZYRA Data at IDWeek..
02/10/202306:33EDGAR2Form 15-12G - Securities registration termination [Section..
25/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
21/9/202312:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202312:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/9/202309:59EDGAR2Form SC 13E3/A - Going private transaction by certain..
21/9/202309:42EDGAR2Form POS AM - Post-Effective amendments for registration..
21/9/202309:39EDGAR2Form S-8 POS - Securities to be offered to employees in..
21/9/202308:10EDGAR2Form 25-NSE - Notification filed by national security..
21/9/202308:07EDGAR2Form 8-K - Current report
21/9/202307:58GLOBEGurnet Point Capital and Novo Holdings A/S Complete..
18/9/202316:23EDGAR2Form SC 13E3/A - Going private transaction by certain..
18/9/202311:49EDGAR2Form 8-K - Current report
12/9/202316:08EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202315:21EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/9/202315:19EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202308:14EDGAR2Form SC 13E3/A - Going private transaction by certain..
11/9/202306:46EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
11/9/202306:42EDGAR2Form 8-K - Current report
07/9/202315:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/8/202315:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/8/202315:31EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
22/8/202315:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18/8/202315:36EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
16/8/202315:50EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
14/8/202316:13EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
10/8/202319:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202319:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202319:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202319:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202319:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202313:37BWInvestor Alert: Abbott Cooper PLLC Announces Investigation..
03/8/202307:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202307:00GLOBEParatek Pharmaceuticals Announces Second Quarter 2023..
02/8/202316:28EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/8/202316:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
02/8/202316:03EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
28/7/202313:01EDGAR2Form SC 13E3/A - Going private transaction by certain..
28/7/202311:55EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
11/7/202315:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..

Su Consulta Reciente

NASDAQ
PRTK
Paratek Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados